Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Cornblath

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Annals of Neurology|March 1, 1990
Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodiesA Pestronk, V Chaudhry, E L Feldman, et al.
Annals of Neurology|May 1, 1988
Serum antibodies to gangliosides in Guillain-Barré syndromeA A Ilyas, H J Willison, R H Quarles, et al.
Lancet (London, England)|September 7, 1991
Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern ChinaG M McKhann, D R Cornblath, T Ho, et al.
Annals of Neurology|November 1, 1989
Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the multicenter AIDS Cohort StudyJ C McArthur, B A Cohen, O A Selnes, et al.
Neurology|March 29, 2001
Preceding infections, immune factors, and outcome in Guillain-Barré syndromeR D Hadden, H Karch, H P Hartung, et al.
Journal of Neurocytology|January 1, 1996
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndromeJ W Griffin, C Y Li, C Macko, et al.
Annals of Neurology|January 1, 1996
Pathology of the motor-sensory axonal Guillain-Barré syndromeJ W Griffin, C Y Li, T W Ho, et al.
Neurology|January 15, 2000
Physiologic-pathologic correlation in Guillain-Barré syndrome in childrenJ L Lu, K A Sheikh, H S Wu, et al.
Neurology|March 1, 1997
Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infectionT W Ho, S T Hsieh, I Nachamkin, et al.
Neurology|September 25, 2003
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of NeurologyR A C Hughes, E F M Wijdicks, R Barohn, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Annals of Neurology|March 1, 1990
Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodiesA Pestronk, V Chaudhry, E L Feldman, et al.
Annals of Neurology|May 1, 1988
Serum antibodies to gangliosides in Guillain-Barré syndromeA A Ilyas, H J Willison, R H Quarles, et al.
Lancet (London, England)|September 7, 1991
Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern ChinaG M McKhann, D R Cornblath, T Ho, et al.
Annals of Neurology|November 1, 1989
Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the multicenter AIDS Cohort StudyJ C McArthur, B A Cohen, O A Selnes, et al.
Neurology|March 29, 2001
Preceding infections, immune factors, and outcome in Guillain-Barré syndromeR D Hadden, H Karch, H P Hartung, et al.
Journal of Neurocytology|January 1, 1996
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndromeJ W Griffin, C Y Li, C Macko, et al.
Annals of Neurology|January 1, 1996
Pathology of the motor-sensory axonal Guillain-Barré syndromeJ W Griffin, C Y Li, T W Ho, et al.
Neurology|January 15, 2000
Physiologic-pathologic correlation in Guillain-Barré syndrome in childrenJ L Lu, K A Sheikh, H S Wu, et al.
Neurology|March 1, 1997
Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infectionT W Ho, S T Hsieh, I Nachamkin, et al.
Neurology|September 25, 2003
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of NeurologyR A C Hughes, E F M Wijdicks, R Barohn, et al.
Pageof 15